Contenido principal del artículo

AM Galmés-Panadés
Institut d’Investigació Sanitària Illes Balears (IdISBa)
España
Biografía
J Konieczna
Institut d’Investigació Sanitària Illes Balears (IdISBa)
España
Biografía
A Colom
Institut d’Investigació Sanitària Illes Balears (IdISBa), España. CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III,
España
Biografía
M Morey
Institut d’Investigació Sanitària Illes Balears (IdISBa), España. CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III
España
Biografía
D Romaguera
Institut d’Investigació Sanitària Illes Balears (IdISBa), España. CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III
España
Biografía
Vol. 7 Núm. 2 (2018), SUPLEMENTO 7º CONGRESO INTERNACIONAL DE ACTIVIDAD FÍSICA DEPORTIVA PARA MAYORES, Páginas 85-95
DOI: https://doi.org/10.24310/riccafd.2018.v7i2.5092
Derechos de autor Cómo citar

Resumen

La obesidad sarcopénica (OS) es una nueva categoría de obesidad, especialmente asociada a población envejecida, caracterizada por una elevada masa grasa y baja masa muscular.

 Se pretende analizar la relación entre la OS y la disfuncionalidad en una población mayor de 55 años con sobrepeso u obesidad y síndrome metabólico.

Para el análisis de la composición corporal se ha utilizado la absorciometria dual de rayos X (DXA) en un total de 303 participantes, y para la valoración de la disfuncionalidad se han realizado 5 test físicos validados en una submuestra de 53 participantes. Se ha realizado una puntuación global de capacidad física y se ha mirado su asociación con los fenotipos de OS, definidos en función de la masa muscular esquelética y la grasa corporal total. 

No se observó una asociación significativa entre la OS y la disfuncionalidad en esta muestra. Son necesarios estudios con mayor tamaño muestral.

Detalles del artículo

Referencias

1. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol [Internet]. 1998;147(8):755–63. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9554417

2. Stenholm S, Harris TB, Rantanen T, Visser M, Kritchevsky SB, Ferrucci L. Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care [Internet]. 2008;11(6):693–700. Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00075197-200811000-00004%0Ahttp://www.ncbi.nlm.nih.gov/pubmed/18827572%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC2633408

3. Davison KK, Ford ES, Cogswell ME, Dietz WH. Percentage of body fat and body mass index are associated with mobility limitations in people aged 70 and older from NHANES III. J Am Geriatr Soc. 2002;50(11):1802–9.

4. Zoico E, Di Francesco V, Guralnik JM, Mazzali G, Bortolani a, Guariento S, et al. Physical disability and muscular strength in relation to obesity and different body composition indexes in a sample of healthy elderly women. Int J Obes Relat Metab Disord. 2004;28(2):234–41.

5. Newman AB, Kupelian V, Visser M, Simonsick E, Goodpaster B, Nevitt M, et al. Sarcopenia: Alternative Definitions and Associations with Lower Extremity Function. J Am Geriatr Soc. 2003;51(11):1602–9.

6. Baumgartner RN, Wayne SJ, Waters DL, Janssen I, Gallagher D, Morley JE. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res [Internet]. 2004;12(12):1995–2004. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15687401%5Cnhttp://www.nature.com/oby/journal/v12/n12/pdf/oby2004250a.pdf

7. Bouchard DR, Dionne IJ, Brochu M. Sarcopenic/Obesity and Physical Capacity in Older Men and Women: Data From the Nutrition as a Determinant of Successful Aging (NuAge)—the Quebec Longitudinal Study. Obesity [Internet]. 2009;17(11):2082–8. Available from: http://doi.wiley.com/10.1038/oby.2009.109

8. Donini LM, Poggiogalle E, Migliaccio S, Aversa A, Pinto A. Body composition in sarcopenic obesity: Systematic review of the literature. Med J Nutrition Metab. 2013;6(3):191–8.

9. Silva AO, Karnikowski MGO, Funghetto SS, Stival MM, Lima RM, de Souza JC, et al. Association of body composition with sarcopenic obesity in elderly women. Int J Gen Med [Internet]. 2013;6:25–9. Available from: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed11&AN=2013149241%5Cnhttp://sfx.scholarsportal.info/ottawa?sid=OVID:embase&id=pmid:&id=doi:10.2147%2FIJGM.S36279&issn=1178-7074&isbn=&volume=6&issue=&spage=25&pages=25-29&date=2013&ti

10. Kim TN, Park MS, Lee EJ, Chung HS, Yoo HJ, Kang HJ, et al. Comparisons of three different methods for defining sarcopenia: An aspect of cardiometabolic risk. Sci Rep [Internet]. 2017;7(1):6491. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28747657%0Ahttp://www.nature.com/articles/s41598-017-06831-7

11. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing. 2010;39(4):412–23.

12. Gianoudis J, Bailey CA, Daly RM. Associations between sedentary behaviour and body composition, muscle function and sarcopenia in community-dwelling older adults. Osteoporos Int. 2014;26(2):571–9.

13. Aggio DA, Sartini C, Papacosta O, Lennon LT, Ash S, Whincup PH, et al. Cross-sectional associations of objectively measured physical activity and sedentary time with sarcopenia and sarcopenic obesity in older men. Prev Med (Baltim) [Internet]. 2016;91:264–72. Available from: http://dx.doi.org/10.1016/j.ypmed.2016.08.040

14. Nuria Rosique-Esteban, Andrés Díaz-López, Miguel A. Martínez-González, Dolores Corella, Albert Goday, J. Alfredo Martínez, Dora Romaguera, Jesus Vioque, Fernando Arós, Antonio Garcia-Rios, Francisco Tinahones, Ramon Estruch, José Carlos Fernández-García, José Lapetra, Luís Serra-Majem, Xavier Pinto, Josep A. Tur, Aurora Bueno-Cavanillas, Josep Vidal, Miguel Delgado-Rodríguez, Lidia Daimiel, Clotilde Vázquez, Miguel Ángel Rubio, Emilio Ros, Jordi Salas-Salvadó , PREDIMED-PLUS investigators. Leisure-time physical activity, sedentary behaviors, sleep, and cardiometabolic risk factors at baseline in the PREDIMED-PLUS intervention trial: A cross-sectional analysis. PLoS One. 2017;12(3):1–19.

15. Dominguez LJ, Barbagallo M. The cardiometabolic syndrome and sarcopenic obesity in older persons. J Cardiometab Syndr. 2007;2(3):183–9.

16. Zamboni M, Mazzali G, Fantin F, Rossi A, Di Francesco V. Sarcopenic obesity: A new category of obesity in the elderly. Nutr Metab Cardiovasc Dis. 2008;18(5):388–95.

17. Padilla J. Relación Del Índice De Masa Corporal Y El Porcentaje De Grasa Corporal En Jóvenes Venezolanos Relationship of Body Mass Index and Body Fat Percentage in Young Venezolanos. Revista Iberoamericana de Ciencias de la Actividad Física y el Deporte. 2014;3(1):27–33.

18. Monleón C.1, Fargueta, M.2y Elvira L. Piafarc effects on densitometry in obese physical condition. Revista Iberoamericana de Ciencias de la Actividad Física y el Deporte. 2015;4(3):11–20.

19. Park S, Goodpaster B, Strotmeyer E, Kuller L, Broudeau R, Kammerer C, et al. Accelerated Loss of Skeletal Muscle Strength in Older Adults With Type 2 Diabetes The health, aging, and body composition study. Diabetes Care [Internet]. 2007;30(6):1507–12. Available from: http://care.diabetesjournals.org:8080/content/30/6/1507.short%5Cnhttp://care.diabetesjournals.org/content/30/6/1507.short

20. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International . Circulation. 2009;120(16):1640–5.

21. Zamboni M, Zoico E, Scartezzini T, Mazzali G, Tosoni P, Zivelonghi A, et al. Body composition changes in stable-weight elderly subjects: the effect of sex. Aging Clin Exp Res [Internet]. 2003;15(4):321–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14661824

22. Atkins JL, Whincup PH, Morris RW, Lennon LT, Papacosta O, Wannamethee SG. Sarcopenic obesity and risk of cardiovascular disease and mortality: A population-based cohort study of older men. J Am Geriatr Soc. 2014;62(2):253–60.

23. Cesari M, Kritchevsky SB, Baumgartner RN, Atkinson HH, Penninx BW, Lenchik L, et al. Sarcopenia, obesity, and inflammation - Results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study. Am J Clin Nutr [Internet]. 2005;82:428–34. Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L354104215%5Cnhttp://dx.doi.org/10.1016/j.ahj.2008.10.026%5Cnhttp://nihlibrarysfx.nih.gov:9003/sfx_local?sid=EMBASE&issn=00028703&id=doi:10.1016/j.ahj.2008.10.026&atitle=Angiotensin-

24. Jones CJ, Rikli RE, Beam WC. A 30-s chair-stand test as a measure of lower body strength in community-residing older adults. Res Q Exerc Sport. 1999;70(2):113–9.

25. Aubertin-Leheudre M, Lord C, Goulet ED, Khalil A, Dionne IJ. Effect of sarcopenia on cardiovascular disease risk factors in obese postmenopausal women 165. Obes. 2006;14(1930–7381 (Print)):2277–83.